Observational studyJournal of opioid management
Medications for opioid use disorder receipt in intensive care patients with opioid use disorder-A statewide cohort study.
Observational study in Journal of opioid management. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
designRetrospective observational study.
settingSeven intensive care units (ICUs) across the MaineHealth system. PATIENTS: Adults with opioid use disorder (OUD) admitted to the ICU between November 2023 and June 2025.
interventionNone. MEASURES: Receipt of medications for OUD (M-OUD) assessed preadmission, during hospitalization (ICU and general ward), and at discharge, stratified by prior treatment status and hospital rurality.
resultsAmong 1,113 patients, 15.6 percent were on M-OUD preadmission. M-OUD exposure increased during ICU care, with no significant difference between urban and rural patients (44 percent vs 39 percent, p = 0.134). On the general ward, M-OUD exposure decreased: 29.8 percent of previously untreated patients received M-OUD, while 57.2 percent of those on preadmission M-OUD did not receive therapy (p < 0.001). At discharge, M-OUD prescribing was significantly lower in rural versus urban patients (8 percent vs 22 percent, p < 0.001).
conclusionM-OUD remains underutilized across the ICU care continuum, with loss of treatment continuity at discharge for rural and urban patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.